Randomized phase-III-trial of concurrent chemoradiation for locally advanced head and neck cancer comparing dose reduced radiotherapy with paclitaxel/cisplatin to standard radiotherapy with fluorouracil/cisplatin: The PacCis-trial
KEY PUBLICATIONS OF LARYNGEAL CANCER & OROPHARYNGEAL CANCER - PART 2
Chairpersons :
Subhashini John, Radiation Oncologist, Vellore, Kaustubh Patel, Surgical Oncologist, Ahmedabad
Speaker :
Trinanjan Basu